25 ± 0.05 (2) 3.18 ± 0.88 (2) NDd 6.38 ± 6.44 7 d 65.92 ± 22.87 (2) 1.36 (1) ND 9.34 ± 8.99 14 d 14.71 ± 7.27 (2) 1.59 ± 0.58 (2) ND 9.96 ± 9.09 ATCC 62762 W Start 0.12 ± 0.02 (2) 0.20 ± 0.02 (2) 0.2 6.1 ± 5.91 7 d 50.1 ± 5.35 (2) 1.43 ± 0.24 (2) < 0.2 6.59 ± 6.03 14 {Selleck Anti-diabetic Compound Library|Selleck Antidiabetic Compound Library|Selleck Anti-diabetic Compound Library|Selleck Antidiabetic Compound Library|Selleckchem Anti-diabetic Compound Library|Selleckchem Antidiabetic Compound Library|Selleckchem Anti-diabetic Compound Library|Selleckchem Antidiabetic Compound Library|Anti-diabetic Compound Library|Antidiabetic Compound Library|Anti-diabetic Compound Library|Antidiabetic Compound Library|Anti-diabetic Compound Library|Antidiabetic Compound Library|Anti-diabetic Compound Library|Antidiabetic Compound Library|Anti-diabetic Compound Library|Antidiabetic Compound Library|Anti-diabetic Compound Library|Antidiabetic Compound Library|Anti-diabetic Compound Library|Antidiabetic Compound Library|Anti-diabetic Compound Library|Antidiabetic Compound Library|Anti-diabetic Compound Library|Antidiabetic Compound Library|buy Anti-diabetic Compound Library|Anti-diabetic Compound Library ic50|Anti-diabetic Compound Library price|Anti-diabetic Compound Library cost|Anti-diabetic Compound Library solubility dmso|Anti-diabetic Compound Library purchase|Anti-diabetic Compound Library manufacturer|Anti-diabetic Compound Library research buy|Anti-diabetic Compound Library order|Anti-diabetic Compound Library mouse|Anti-diabetic Compound Library chemical structure|Anti-diabetic Compound Library mw|Anti-diabetic Compound Library molecular weight|Anti-diabetic Compound Library datasheet|Anti-diabetic Compound Library supplier|Anti-diabetic Compound Library in vitro|Anti-diabetic Compound Library cell line|Anti-diabetic Compound Library concentration|Anti-diabetic Compound Library nmr|Anti-diabetic Compound Library in vivo|Anti-diabetic Compound Library clinical trial|Anti-diabetic Compound Library cell assay|Anti-diabetic Compound Library screening|Anti-diabetic Compound Library high throughput|buy Antidiabetic Compound Library|Antidiabetic Compound Library ic50|Antidiabetic Compound Library price|Antidiabetic Compound Library cost|Antidiabetic Compound Library solubility dmso|Antidiabetic Compound Library purchase|Antidiabetic Compound Library manufacturer|Antidiabetic Compound Library research buy|Antidiabetic Compound Library order|Antidiabetic Compound Library chemical structure|Antidiabetic Compound Library datasheet|Antidiabetic Compound Library supplier|Antidiabetic Compound Library in vitro|Antidiabetic Compound Library cell line|Antidiabetic Compound Library concentration|Antidiabetic Compound Library clinical trial|Antidiabetic Compound Library cell assay|Antidiabetic Compound Library screening|Antidiabetic Compound Library high throughput|Anti-diabetic Compound high throughput screening| d 12.26 ± 0.78 (2) 1.75 ± 0.11 (2) 0.2 7.31 ± 6.83 21 d 5.10 ± 0.18 (2) 1.34 ± 0.11 (2) 2.0 6.90 ± 6.56 28 d 2.52 (1) 0.46 (1) > 18 8.25 ± 7.45 ATCC 34916 W start 0.34 ± 0.12 (2) BDLe < 0.2 TFTC 7 d 57.85 ± 5.03 (2) 1.83 ± 0.80 (2) > 18 9.45 ± 8.48 14 d 13.10 ± 0.21 (2) 2.31 ± 0.65 (2) > 18 9.94 ± 9.31 21 d 6.57 ± 0.08 (2) 2.23 ± 0.56 (2) > 18 10.45 ± 9.95 28 d 3.75 (1) 0.54 (1) > 18 9.9 ± 9.19 ATCC
208877 W Start 0.62 ± 0.09 (3) 1.44 ± 0.19 (2) < 0.2 5 7 d 105.19 ± 37.96 (3) 4.37 ± 0.71 (2) 0.2 < x < 2.0 7.99 ± 7.40 14 d 36.58 ± 10.44 (2) 2.52 ± 0.45 (2) 18 9.55 ± 8.9 21 d 18.72 (1) 2.45 (1) 2.0 < x < 18 9.49 ± 9.06 ATCC 46994 W Start 0.75 ± 0.05 (2) 0.28 (1) < 0.2 TFTC 7 d 46.37 ± 6.78 (2) 2.16 ± 0.06 (2) 0.2 8.86 ± 8.83 14 d 11.60 ± 2.31 (2) 4.16 ± 0.79 (2) 0.2 < x < 2.0 9.78 ± 9.30 21 d 6.25 ± 0.76 (2) 3.77 ± 0.65 (2) 0.2 < x < 2.0 10.10 ± 9.52 28 d 4.56 (1) 6.16 (1) 0.2 < x < 2.0 10.47 ± 9.32
RTI 3559 BIX 1294 W Start 0.15 ± 0.03 (2) 0.26 ±0.15 (2) 0.2 6.22 ± 5.61 7 d 48.15 ± 7.39 (2) 0.94 (1) 18 8.96 ± 9.07 14 d 9.64 (1) 0.13 (1) 18 10.36 ± 9.64 21 d 4.89 ± 0.64 (2) 0.71 ± 0.04 (2) 18 10.29 ± 9.82 28 d 3.16 (1) 0.94 (1) > 18 9.27 ± 8.36 RTI 5802 W Start 0.58 ± 0.11 (3) 2.22 ± 1.60 (2) < 0.2 5.22 ± 4.76 7 d 61.74 ± 12.72 (3) 1.71 ± 0.23 (2) 0.2 8.5 ± 7.53 14 d 39.32 ± 17.57 (2) 1.40 ± 1.73
(2) 0.2 9.34 ± 8.99 21 d 17.38 (1) 3.18 (1) 2.0 10.45 ± 9.40 aW, gypsum wallboard; bSD, standard deviation; cn, number of chambers with same strain, tested during same incubation period; dND, not determined; eBDL, below detection limit. Table 2 Growth, MVOC many emissions and mycotoxin production by Stachybotrys chartarum growing on ceiling tile Stachybotrys chartarum strain Substratea Incubation period Anisole CX-5461 manufacturer concentration 3-octanone concentration Mycotoxin concentration CFU log10 (Days) (μg/m3) (μg/m3) (ppb) Mean ± SD Mean ± SDb (n)c Mean ± SD (n) ATCC 201210 C Start 0.15 (2) BDLe NDd ND 7 d 12.91 ± 3.29 (2) BDL ND ND 14 d 6.51 ± 0.26 (2) BDL ND ND 21 d 3.86 ± 0.05 (2) BDL ND ND ATCC 62762 C Start 1.45 ± 0.35 (2) 2.77 ± 0.45 (2) < 0.2 TFTC 7 d 13.97 ± 2.50 (2) 8.68 ± 0.42 (2) 18 8.07 ± 7.55 14 d 5.94 ± 0.47 (2) 2.02 ± 0.59 (2) 18 8.07 ± 7.55 21 d 7.33 ± 0.21 (2) 1.49 ± 0.36 (2) > 18 8.95 ± 8.74 ATCC 34916 C Start 0.28 ± 0.01 (2) 0.40 ± 0.09 (2) < 0.2 TFTC 7 d 46.41 ± 1.25 (2) 1.32 ± 0.41 (2) > 18 9.9 ± 9.19 14 d 5.78 ± 0.53 (2) 1.42 ± 0.06 (2) > 18 9.54 ± 9.05 21 d 3.09 ± 0.37 (2) 1.73 ± 0.66 (2) > 18 9.66 ± 9.22 28 d 2.08 ± 0.14 (2) 3.56 ± 0.10 (2) 18 8.02 ± 8.00 ATCC 46994 C Start 2.28 ± 0.02 (2) 1.57 ± 0.55 (2) < 0.2 5.76 ± 5.